188 related articles for article (PubMed ID: 30878232)
1. Routine monitoring for heparin-induced thrombocytopenia following lower limb arthroplasty: Is it necessary? A prospective study in a UK district general hospital.
Haughton B; Haughton J; George Norman J; Navid A; Allport K; Andrews M; Mannan K; Livesey J
Orthop Traumatol Surg Res; 2019 May; 105(3):497-501. PubMed ID: 30878232
[TBL] [Abstract][Full Text] [Related]
2. Heparin-induced thrombocytopenia following hip and knee arthroplasty.
Craik JD; Cobb AG
Br J Haematol; 2013 Apr; 161(2):255-61. PubMed ID: 23406088
[TBL] [Abstract][Full Text] [Related]
3. [Heparin-induced thrombocytopenia after elective hip joint replacement with postoperative prevention of thromboembolism with low-molecular-weight heparin].
Marx A; Huhle G; Hoffmann U; Wang LC; Schüle B; Jani L; Harenberg J
Z Orthop Ihre Grenzgeb; 1999; 137(6):536-9. PubMed ID: 10666863
[TBL] [Abstract][Full Text] [Related]
4. The management of heparin-induced thrombocytopenia.
Keeling D; Davidson S; Watson H;
Br J Haematol; 2006 May; 133(3):259-69. PubMed ID: 16643427
[TBL] [Abstract][Full Text] [Related]
5. Prevention of postoperative venous thromboembolism in Japanese patients undergoing total hip or knee arthroplasty: two randomized, double-blind, placebo-controlled studies with three dosage regimens of enoxaparin.
Fuji T; Ochi T; Niwa S; Fujita S
J Orthop Sci; 2008 Sep; 13(5):442-51. PubMed ID: 18843459
[TBL] [Abstract][Full Text] [Related]
6. The study of the thrombin generation mechanism and the effect of low molecular weight heparin as thromboprophylaxis in patients undergoing total knee and hip replacement.
Gionis MN; Ioannou CV; Katsamouris AN; Katonis P; Balalis K; Sfyridaki K; Elalamy I; Gerotziafas GT
Thromb Res; 2013; 132(6):685-91. PubMed ID: 24182549
[TBL] [Abstract][Full Text] [Related]
7. [Potentials risks in drug prevention of thrombosis--low-molecular-weight heparin versus standard heparin].
Ganzer D; Gutezeit A; Mayer G
Z Orthop Ihre Grenzgeb; 1999; 137(5):457-61. PubMed ID: 10549126
[TBL] [Abstract][Full Text] [Related]
8. [Significance and incidence of type II heparin-induced thrombocytopenia. A prospective study].
Mahlfeld K; Böck M; Franke J; Meinecke I; Schaeper O; Kayser R; Grasshoff H
Zentralbl Chir; 2001 Jan; 126(1):39-43. PubMed ID: 11227292
[TBL] [Abstract][Full Text] [Related]
9. [Prevention of thromboembolism as a cause of thromboembolic complications. A study of the incidence of heparin-induced thrombocytopenia type II].
Ganzer D; Gutezeit A; Mayer G; Greinacher A; Eichler P
Z Orthop Ihre Grenzgeb; 1997; 135(6):543-9. PubMed ID: 9499523
[TBL] [Abstract][Full Text] [Related]
10. An improved definition of immune heparin-induced thrombocytopenia in postoperative orthopedic patients.
Warkentin TE; Roberts RS; Hirsh J; Kelton JG
Arch Intern Med; 2003 Nov; 163(20):2518-24. PubMed ID: 14609790
[TBL] [Abstract][Full Text] [Related]
11. Spontaneous HIT syndrome post-knee replacement surgery with delayed recovery of thrombocytopenia: a case report and literature review.
Poudel DR; Ghimire S; Dhital R; Forman DA; Warkentin TE
Platelets; 2017 Sep; 28(6):614-620. PubMed ID: 28856946
[TBL] [Abstract][Full Text] [Related]
12. Fondaparinux-related thrombocytopenia in a previous low-molecular-weight heparin (LMWH)-induced heparin-induced thrombocytopenia (HIT).
Rota E; Bazzan M; Fantino G
Thromb Haemost; 2008 Apr; 99(4):779-81. PubMed ID: 18392338
[No Abstract] [Full Text] [Related]
13. Comparative Analysis of the Suspected Heparin-Induced Thrombocytopenia Level in Korea.
Kim HS; Kim H; Jeong YJ; Lee H; Yim HW; Kim JI; Moon IS; Kim JY
Basic Clin Pharmacol Toxicol; 2017 Oct; 121(4):360-367. PubMed ID: 28374942
[TBL] [Abstract][Full Text] [Related]
14. A cohort study investigating compliance with guidelines for platelet count monitoring during heparin thromboprophylaxis.
Kim S; Trick WE
Hosp Pract (1995); 2012 Apr; 40(2):88-95. PubMed ID: 22615083
[TBL] [Abstract][Full Text] [Related]
15. Utilization Patterns, Efficacy, and Complications of Venous Thromboembolism Prophylaxis Strategies in Primary Hip and Knee Arthroplasty as Reported by American Board of Orthopedic Surgery Part II Candidates.
Runner RP; Gottschalk MB; Staley CA; Pour AE; Roberson JR
J Arthroplasty; 2019 Apr; 34(4):729-734. PubMed ID: 30685257
[TBL] [Abstract][Full Text] [Related]
16. Prolonged enoxaparin therapy to prevent venous thromboembolism after primary hip or knee replacement. Enoxaparin Clinical Trial Group.
Comp PC; Spiro TE; Friedman RJ; Whitsett TL; Johnson GJ; Gardiner GA; Landon GC; Jové M;
J Bone Joint Surg Am; 2001 Mar; 83(3):336-45. PubMed ID: 11263636
[TBL] [Abstract][Full Text] [Related]
17. Risk factors and distribution of symptomatic venous thromboembolism in total hip and knee replacements: prospective study.
Markovic-Denic L; Zivkovic K; Lesic A; Bumbasirevic V; Dubljanin-Raspopovic E; Bumbasirevic M
Int Orthop; 2012 Jun; 36(6):1299-305. PubMed ID: 22215369
[TBL] [Abstract][Full Text] [Related]
18. [Heparin-induced thrombocytopenia as a complication of postoperative prevention of thromboembolism with unfractionated heparin/low molecular weight heparin after hip and knee prosthesis implantation].
Mahlfeld K; Franke J; Schaeper O; Kayser R; Grasshoff H
Unfallchirurg; 2002 Apr; 105(4):327-31. PubMed ID: 12066471
[TBL] [Abstract][Full Text] [Related]
19. Heparin-induced thrombocytopenia: recognition, treatment, and prevention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Warkentin TE; Greinacher A
Chest; 2004 Sep; 126(3 Suppl):311S-337S. PubMed ID: 15383477
[TBL] [Abstract][Full Text] [Related]
20. The incidence of symptomatic venous thromboembolism during and after prophylaxis with enoxaparin: a multi-institutional cohort study of patients who underwent hip or knee arthroplasty. Canadian Collaborative Group.
Leclerc JR; Gent M; Hirsh J; Geerts WH; Ginsberg JS
Arch Intern Med; 1998 Apr; 158(8):873-8. PubMed ID: 9570173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
